Kingston, MA, United States of America

Edward P Ingenito

This inventor holds 16 USPTO granted patents and 1 published patent application and 1 EPO patent, primarily in Lung Volume Reduction. Top assignees: Aeris Therapeutics, Inc., Bistech, Inc., The Brigham and Women's Hospital, Inc.. Active years: 2003-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Edward P Ingenito. Retrieved from https://idiyas.com/inventor/edward-p-ingenito

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 16 

% Patents Active = 81.3

 

Average Co-Inventor Count = 1.7

ph-index = 9

Forward Citations = 847(Granted Patents)


Location History:

  • Kingston, MA (US) (2003 - 2011)
  • North Quincy, MA (US) (2012 - 2018)

Company Filing History:


Years Active: 2003-2018

Loading Chart...
Loading Chart...
Areas of Expertise:
Lung Volume Reduction
Crosslinked Polymers
Biopolymers
Respiratory Assistance
Tissue Volume Reduction
Ventilation Methods
Prosthetic Devices
Compositions
Therapy
Non-Natural Polymers
Polymer Systems
Variable Peak Pressure
16 patents (USPTO):Explore Patents

Title: Innovations of Edward P Ingenito

Introduction

Edward P Ingenito is a notable inventor based in Kingston, MA (US), recognized for his significant contributions to medical technology. With a total of 16 patents to his name, Ingenito has focused on developing innovative solutions for lung-related therapies.

Latest Patents

Ingenito's latest patents revolve around lung volume reduction therapy using crosslinked non-natural polymers. One aspect of his invention involves a hydrogel that comprises a non-natural polymer with a plurality of pendant nucleophilic groups and a crosslinker featuring at least two pendant electrophilic groups. Another aspect includes a hydrogel with a non-natural polymer containing a plurality of pendant electrophilic groups and a crosslinker with at least two pendant nucleophilic groups. Additionally, Ingenito has developed a method for reducing lung volume in patients by administering a hydrogel composition. These hydrogels can be utilized for various medical applications, including achieving pleurodesis, sealing brochopleural fistulas, sealing air leaks in lungs, achieving hemostasis, and tissue sealing for blood vessels and internal organs. His inventions are particularly aimed at treating patients with emphysema.

Career Highlights

Throughout his career, Ingenito has worked with several companies, including Aeris Therapeutics, Inc. and Bistech, Inc. His work has significantly impacted the field of respiratory therapies, showcasing his dedication to improving patient outcomes.

Collaborations

Ingenito has collaborated with notable professionals in his field, including Larry W Tsai and Alexander Schwarz. These collaborations have further enhanced the development and application of his innovative technologies.

Conclusion

Edward P Ingenito's contributions to lung volume reduction therapy highlight his role as a leading inventor in medical technology. His innovative approaches continue to pave the way for advancements in the treatment of respiratory conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…